Growing Role of Glycomics in Disease Diagnostics and Drug Development will drive Glycomics Market Growth
Glycomics refers to the study of the entire complement of glycans or sugars in a biological sample or organism. It involves the analysis of sugar chains or glycans attached to proteins and lipids. Glycomics provides useful information for understanding various biological processes such as cell signaling, immune response and development of diseases like cancer. Glycomics helps in developing tools and technologies for disease diagnostics, drug discovery and personalized medicine. The growing demand for personalized medicine is anticipated to drive the growth of the glycomics market during the forecast period.
The global glycomics market size is estimated to be valued at US$ 1.99 Bn in 2024 and is expected to exhibit a CAGR of 13.% over the forecast period 2024 to 2031. Glycomics research focuses on analyzing and characterizing glycans and studying their roles. It aids in developing therapies and diagnostics targeted to individual patients based on their specific disease conditions. With rising focus on precision medicine globally, glycomics is gaining increasing attention from pharmaceutical and biotechnology companies.
Key Takeaways
The opportunities in the glycomics market include potential applications in disease diagnosis, biomarker discovery and drug development. Glycomics research can aid in understanding disease pathology at molecular level and identification of novel drug targets. Further, rising R&D investments by pharmaceutical and biotechnology companies and growing glycomics applications in academics are boosting market opportunities.
Glycomics Companies operating in the glycomics market are RayBiotech Life, Inc., Shimadzu Corporation, Asparia Glycomics, Agilent Technologies Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Merck KgaA, New England Biolabs, Takara Bio Inc, Waters Corporation, Danaher, Lectenz Bio, GlycoMimetics, Inc., Ludger Ltd., GlycoTech Corporation, Glycosyn LLC, Glykos, Inc., and Glanbia PLC. These players are focusing on strengthening their product portfolios through partnerships, acquisitions and new product launches.
Key players are expanding their global footprint to tap growth opportunities in emerging markets. The partnerships between global and local players will also support technology transfers and skill development in developing regions. North America and Europe currently dominate the glycomics market. However, Asia Pacific is expected to offer high growth potential during the forecast period.
Market Drivers
Rising demand for personalized medicine:
The growing need for personalized therapies targeted to individual patients is a key factor driving the glycomics market. Glycomics research helps in discovering biomarkers for disease diagnosis and personalized treatment approaches. This increases the demand for glycans analysis techniques and tools.
Market Restrains
High costs of glycomics instruments:
The instruments and tools required for glycomics research and analysis are highly expensive. This restrains widespread adoption of glycomics especially in academic institutes and developing regions. Technological advancements are needed to develop low-cost glycomics solutions for propelling market growth.
Segment Analysis
The glycomics market is dominated by the research segment, which holds over 40% share in 2024. The increasing research activities pertaining to understanding glycan structures, functions in normal and diseased conditions has propelled growth of this segment. Moreover, glycans are actively studied to develop glycan-based therapeutics and diagnostics.
Services segment is the fastest growing segment, projected to witness a CAGR of 15% during the forecast period. This is attributed to increasing outsourcing of analytical services by pharmaceutical and biotechnology companies to CROs and academic research institutes. Further, CROs provide array of N-glycan and O-glycan related services including glycosylation analysis, structural characterization and functional studies.
Global Analysis
North America dominated the global glycomics market in 2024 and is anticipated to maintain its dominance during the forecast period. This is owing to presence of major market players, rising glycomics research funding, and growing application of glycomics in disease diagnostics and drug discovery in the region. For instance, surge in funding for research by National Institutes of Health (NIH) in the US acts as a major driver.
Asia Pacific exhibits the fastest growth over the next 8 years, anticipated to expand at a CAGR of around 15% from 2024-2031. Growing biomedical sector and advancing research infrastructure in emerging economies such as China and India provides lucrative growth opportunities. Moreover, improving R&D expenditure, increase in pharmaceutical outsourcing and rising awareness regarding Value of glycomics studies in the region drive the market growth.
Author Bio:
Ravina Pandya,
Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Get More Insight @ Glycomics Market
Comments
0 comment